Cited by 384Hematopoietic Stem Cell TransplantationGut microbiota and healthNeutropenia and Cancer Infections

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Lactose drives Enterococcus expansion to promote graft-versus-host disease

Open access

Stein-Thoeringer, C. K., Nichols, K. B., Lazrak, A., Docampo, M. D., Slingerland, A. E., Slingerland, J. B., Clurman, A. G., Armijo, G., Gomes, A. L. C., Shono, Y., Staffas, A., Burgos da Silva, M., Devlin, S. M., Markey, K. A., Bajic, D., Pinedo, R., Tsakmaklis, A., Littmann, E. R., Pastore, A., Taur, Y., Monette, S., Arcila, M. E., Pickard, A. J., Maloy, M., Wright, R. J., Amoretti, L. A., Fontana, E., Pham, D., Jamal, M. A., Weber, D., Sung, A. D., Hashimoto, D., Scheid, C., Xavier, J. B., Messina, J. A., Romero, K., Lew, M., Bush, A., Bohannon, L., Hayasaka, K., Hasegawa, Y., Vehreschild, M. J. G. T., Cross, J. R., Ponce, D. M., Perales, M. A., Giralt, S. A., Jenq, R. R., Teshima, T., Holler, E., Chao, N. J., Pamer, E. G., Peled, J. U., van den Brink, M. R. M.·2019·Science

DOI 10.1126/science.aax3760PMC PMC7003985

Open this paper in CoChat — free account Open PDF

Abstract

Lactose can fuel GVHD: Allogeneic hematopoietic cell transplantation (allo-HCT) is used to treat certain hematopoietic malignancies, but patients have a risk of developing graft-versus-host disease (GVHD). Stein-Thoeringer et al. performed a large-scale analysis of more than 1300 patients treated with allo-HCT across four clinical centers (see the Perspective by Zitvogel and Kroemer). High levels of bacteria from the Enterococcus genus were associated with greater incidence of GVHD and mortality. Lactose appears to provide a substrate for Enterococcus growth, and patients with a lactose-malabsorption genotype had a greater abundance of Enterococcus. A lactose-free diet limited Enterococcus growth, reduced the severity of GVHD, and improved survival in gnotobiotic mouse models. Science , this issue p. 1143 ; see also p. 1077

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.aax3760

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 21,481
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
VSEARCH: a versatile open source tool for metagenomics
(2016) · doi:10.7717/peerj.2584 · Cited by 10,773
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes
Brettin, T. S., Davis, J. J., Disz, T. L., Edwards, R. A., Gerdes, S., Olsen, G. J., Olson, R., Overbeek, R., Parrello, B., Pusch, G. D., et al. (2015) · Scientific Reports · doi:10.1038/srep08365 · Cited by 2,860
Dysbiosis and the immune system
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769
Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., Degnan, P. H., Hu, J., Peter, I., Zhang, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.006 · Cited by 1,286
Strains, functions and dynamics in the expanded Human Microbiome Project
Lloyd-Price, J., Mahurkar, A., Rahnavard, G., Crabtree, J., Orvis, J., Hall, A. B., Brady, A., Creasy, H. H., McCracken, C., Giglio, M. G., et al. (2017) · Nature · doi:10.1038/nature23889 · Cited by 1,267

Flagged first, then by citations

Show all 55 references

Research works printed but not linked: 1

T. Tatusova S. Ciufo B. Fedorov K. O’Neill I. Tolstoy L. Zaslavsky “About Prokaryotic Genome Processing and Tools” in The NCBI Handbook [Internet] (National Center for Biotechnology Information ed. 2 2014) pp. 161–174.

Sorted by citations

Items 201–300 of 381

A consortium of seven commensal bacteria promotes gut microbiota recovery and strengthens ecological barrier against vancomycin-resistant enterococci
Jan, A., Bayle, P., Mohellibi, N., Lemoine, C., Pepke, F., Béguet-Crespel, F., Jouanin, I., Tremblay‐Franco, M., Laroche, B., Serror, P., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02127-5 · Cited by 8
Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML—One Step Closer to Personalized Medicine
Nowicka, A., Tomczak, H., Szałek, E., Karbownik, A., & Gil, L. (2025) · Biomedicines · doi:10.3390/biomedicines13071761 · Cited by 8
Rapid identification of novel specific molecular targets for PCR detection of four Enterococcus species
Xiang, X., Lu, J., Xu, X., Hou, X., Diao, E., Qian, S., Song, H., Liang, L., He, Y., & Shang, Y. (2022) · LWT · doi:10.1016/j.lwt.2022.114356 · Cited by 8
The gut microbiota composition and metabolites are different in women with hypertensive disorders of pregnancy and normotension: A pilot study
Wu, Z., Ge, M., Liu, J., Chen, X., Cai, Z., & Huang, H. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15844 · Cited by 8
Gut lactate-producing bacteria promote CD4 T cell recovery on Anti-retroviral therapy in HIV-infected patients
Lyu, W., Meng, Q., Xiao, J., Li, J., Wang, J., Qiu, Z., Song, X., Zhu, H., Shao, C., Chu, Y., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.021 · Cited by 9
Microbiota and Allogeneic Hematopoietic-Cell Transplantation
Peled, J. U., Gomes, A. L. C., & van den Brink, M. R. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2006694 · Cited by 8
Self-citation
Effect of GVHD on the gut and intestinal microflora
Ji, H., Feng, S., Liu, Y., Cao, Y., Lou, H., & Li, Z. (2024) · Transplant Immunology · doi:10.1016/j.trim.2023.101977 · Cited by 11
The role of the universal sugar transport system components PtsI (EI) and PtsH (HPr) in Enterococcus faecium
Hallenbeck, M., Chua, M. J., & Collins, J. (2024) · FEMS Microbes · doi:10.1093/femsmc/xtae018 · Cited by 7
Associations between antibiotic exposure intensity, intestinal microbiome perturbations, and outcomes in premature neonates with bacteremia
Hendricks, H., Israel, S., Weitkamp, J.-H., Pakala, S., Rajagopala, S. V., & Banerjee, R. (2025) · Journal of Perinatology · doi:10.1038/s41372-025-02330-0 · Cited by 7
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients
Leardini, D., Roberto, M., Roggiani, S., Muratore, E., Fabbrini, M., Storci, G., Tomassini, E., Dan, E., Schipani, A., Matteis, S. D., et al. (2025) · Bone Marrow Transplantation · doi:10.1038/s41409-025-02713-z · Cited by 10
Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis
Yan, P., Luo, S., Guo, L., Wang, X., Ren, X., Lv, J., Chen, Y., Lin, X., Chen, J., & Wang, R. (2023) · Microorganisms · doi:10.3390/microorganisms11112747 · Cited by 7
Longitudinal analysis at three oral sites links oral microbiota to clinical outcomes in allogeneic hematopoietic stem-cell transplant
Heidrich, V., Knebel, F. H., Bruno, J. S., de Molla, V. C., Miranda‐Silva, W., Asprino, P. F., Tucunduva, L. T. C. D. M., Rocha, V., Novis, Y. A. S., Fregnani, E. R., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02910-23 · Cited by 8
Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches
Hazra, R., Chattopadhyay, S., Mallick, A., Gayen, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02416-3 · Cited by 8
The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment
Shang, T., Guo, Y., Li, X., Zhou, Z., Qi, Y., Salahdiin, K., Shen, R., He, S., Wang, M., Shi, Z., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112675 · Cited by 7
Nutritional interventions in patients with graft-versus-host disease
Séguy, D., & Hueso, T. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000963 · Cited by 7
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
Vandenhove, B., Canti, L., Schoemans, H. M., Beguin, Y. P., Baron, F., Graux, C., Kerre, T. C. C., & Servais, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583564 · Cited by 9
Chimerism, the Microenvironment and Control of Leukemia
Deeg, H. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652105 · Cited by 7
Diagnosing and engineering gut microbiomes
Barazzone, E. C., Diard, M., Hug, I., Larsson, L., & Slack, E. M. C. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00149-4 · Cited by 7
Influence of ESBL colonization status on gut microbiota composition during allogenic hematopoietic stem cell transplantation
Corcione, S., Ferrocino, I., Lupia, T., Busca, A., Bianco, G., Dellacasa, C. M., Giaccone, L., Brunello, L., Butera, S., Costa, C. S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-85128-6 · Cited by 6
The human gut microbiome in enteric infections: from association to translation
Yin, Q., Gupta, S., Muller, E., & Almeida, A. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2612836 · Cited by 8
Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis
Turner, G., Smith, M., Hoeschen, A. L., Wilson, J. A., Kennedy, J. L., Abramson, M., Cao, Q., Jurdi, N. E., MacMillan, M. L., Weisdorf, D. J., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17238 · Cited by 6
The Promise of Precision Nutrition for Modulation of the Gut Microbiota as a Novel Therapeutic Approach to Acute Graft-versus-host Disease
Lakshmanan, A. P., Deola, S., & Terranegra, A. (2023) · Transplantation · doi:10.1097/tp.0000000000004629 · Cited by 6
Nutritional Strategies To Improve VRE Control
Morello, E., Roversi, S., Brambilla, G., Signorini, L., Lorenzoni, M., Andreoli, M., Bernardi, S., Malagola, M., Farina, M., Radici, V., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.03.007 · Cited by 6
Colonization of vancomycin-resistant Enterococcus faecium in human-derived colonic epithelium: unraveling the transcriptional dynamics of host–enterococcal interactions
Stege, P. B., Beekman, J. M., Hendrickx, A. P. A., van Eijk, L., Rogers, M. R. C., Suen, S. W. F., Vonk, A. M., Willems, R. J. L., & Paganelli, F. L. (2024) · FEMS Microbes · doi:10.1093/femsmc/xtae014 · Cited by 6
Addressing the surge of infections by multidrug-resistant Enterobacterales in hematopoietic cell transplantation
Akhmedov, M., & Espinoza, J. L. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101229 · Cited by 6
Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes
Midani, F. S., Danhof, H. A., Mathew, N., Ardis, C. K., Garey, K. W., Spinler, J. K., & Britton, R. A. (2025) · mSystems · doi:10.1128/msystems.01075-24 · Cited by 6
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 7
Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation
Lindner, S., & Peled, J. U. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000616 · Cited by 6
Self-citation
How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
Aizawa, K., Peltier, D., Matsuki, E., & Toubai, T. (2022) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2022.103405 · Cited by 6
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant
Garcia-Rosa, M., Abraham, A., Bertaina, A., Bhoopalan, S. V., Bonfim, C., Cohen, S., Dezern, A. E., Louis, C. U., Oved, J. H., Pavel-Dinu, M., et al. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.02.007 · Cited by 6
Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host diseasePreprint
Jenq, R. R., Hayase, E., Hayase, T., Mukherjee, A., Stinson, S. C., Jamal, M. A., Ortega, M. R., Sanchez, C., Ahmed, S., Karmouch, J. L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2460097/v1 · Cited by 6
Self-citation
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions
Ye, Y., Hao, W., Malard, F., & Mohty, M. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102649 · Cited by 5
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation
Ebadi, M., Reddi, S., Senyshyn, L., Minot, S. S., Gooley, T. A., Kabage, A. J., Lee, S. J., Hill, G. R., Khoruts, A., & Rashidi, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2551882 · Cited by 5
Isolation, functional characterization and antibiofilm properties of a lytic Enterococcus phage RG1 against multidrug resistant E. faecium
Singh, R. K., Anand, R., Singh, A. P., Rain, Z., Prakash, P., & Maurya, G. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-21701-3 · Cited by 5
Exercise and Diet Reshape Athletes’ Gut Microbiota: Countering Health Challenges in Athletes
Zhang, X., Li, Y., Zhang, F., & Zhou, G. (2025) · Life · doi:10.3390/life15121812 · Cited by 5
Protocol for correlation analysis of the murine gut microbiome and meta-metabolome using 16S rDNA sequencing and UPLC-MS
Li, X., Wu, P., Zeng, X., Lang, Q., Lin, Y., Huang, H., & Qian, P. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101494 · Cited by 5
The Intestinal Microbiota and Therapeutic Responses to Immunotherapy
Herrera, P. S., & van den Brink, M. R. M. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062722-035210 · Cited by 6
Cellular therapies for the prevention and treatment of acute graft-versus-host disease
Peltier, D., Do-Thi, V. A., Devos, T., Blazar, B. R., & Toubai, T. (2025) · Stem Cells · doi:10.1093/stmcls/sxaf009 · Cited by 5
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy
Staudt, S., Ziegler-Martin, K., Visekruna, A., Slingerland, J. B., Shouval, R., Hudecek, M., van den Brink, M. R. M., & Luu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269015 · Cited by 5
Self-citation
Unraveling the Intestinal Microbiota Conundrum in Allogeneic Hematopoietic Stem Cell Transplantation: Fingerprints, Clinical Implications and Future Directions
Ferreira, A. S., da Silva, B. F. R., da Silva, J. L., da Silva, M. T., Feliciano, J. V. P., Colturato, I., Barros, G. M. N., Scheinberg, P., Chao, N. J. A., & de Oliveira, G. L. V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196874 · Cited by 4
Self-citation
Microbiotoxicity: an under-recognised player in drug efficacy, toxicity, and health outcomes
Nascimento, S. S., Theodosiou, A. A., & Sergaki, C. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00165-5 · Cited by 4
Enterococcus faecalis induces MHC-II expression by the intestinal epithelium during murine graft-versus-host disease
Nguyen, C. L., Funes, J., Ghale, R., Duong, N., Victor, K., Gipson, B., Zhang, Z. J., Dai, A., Li, R., Armijo, G. K., et al. (2025) · Blood · doi:10.1182/blood.2024028248 · Cited by 4
Self-citation
Microbiome, GvHD, and immune reconstitution in allogeneic hematopoietic cell transplantation
Weber, D., Tariq, M., Hazenberg, M. D., Poeck, H., & Malard, F. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-02798-0 · Cited by 7
Self-citation
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
Politikos, I., Brown, S., Fein, J. A., Eng, S., Casem, K., Chinapen, S., Quach, S., Scaradavou, A., Cho, C., Dahi, P. B., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014177 · Cited by 4
Self-citation
Fecal Microbial Signatures Are Associated With Engraftment Failure Following Umbilical Cord Blood Transplantation in Pediatric Crohn’s Disease Patients With IL10RA Deficiency
Xue, A., Qian, X., Gao, X., Wang, P., Wang, L., Zheng, C., Huang, Z., Hu, W., Shi, J., & Huang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.580817 · Cited by 4
Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
Gray, A., Tobin, N. H., Moore, T. B., Li, F., & Aldrovandi, G. M. (2023) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2023.151580 · Cited by 4
Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
Mullish, B. H., Innes, A. J., Roberts, L. A., Anim-Burton, S., Webber, L., Johnson, N. A., Ghani, R., Farshi, P., Khan, A. B., Kinsella, F. A. M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-093120 · Cited by 6
Advances in understanding the effects of cardiopulmonary bypass on gut microbiota during cardiac surgery
Zhang, Y., Luo, W., Zhao, M., Li, Y., & Wu, X. (2025) · The International Journal of Artificial Organs · doi:10.1177/03913988251313881 · Cited by 4
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Xie, J., & Smith, M. M. (2024) · Blood · doi:10.1182/blood.2024024219 · Cited by 4
Create a healthy diet after transplant!
Teshima, T. (2020) · Blood · doi:10.1182/blood.2020006611 · Cited by 4
Self-citation
A Distinct Intestinal Domination Fingerprint in Patients Undergoing Allo-HSCT: Dynamics, Predictors and Implications on Clinical Outcomes
Ferreira, A. S., Alvarez, D. A. N., Souza, L. D. A., Silva, N. L., Machado, L. D., Hirai, W. Y., Ciconelli, R. M., Feliciano, J. V. P., Colturato, I., Barros, G. M. N., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238351 · Cited by 3
Self-citation
Overconsumption of fructose aggravates acute GVHD by inducing gut dysbiosis and promoting macrophage-mediated inflammatory response
Wu, K., Yu, H., Cao, K., Dai, B., Yuan, Y., Qian, X., Zhong, H., Qu, Y., Jiang, H., & Chen, T. W. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2642459 · Cited by 4
Modulation of Gut Microbiota Through Dietary Fibers to Enhance Regulatory T Cell-Based Immunotherapy in GVHD Following Hematopoietic Stem Cell Transplantation
Asayesh, M., Nazarzadeh, A., Jamshidi, S., Keramat, S., Ryszkiel, I., & Stanek, A. (2026) · Nutrients · doi:10.3390/nu18081216 · Cited by 3
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational Opportunities
Alvaro, M. E., Caserta, S., Martino, E. A., Skafi, M., Bruzzese, A., Amodio, N., Lucia, E., Olivito, V., Labanca, C., Mendicino, F., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15040417 · Cited by 3
Gut microbiome in children undergoing hematopoietic stem cell transplantation
Józefczuk, P., Biliński, J., Minkowska, A., & Laguna, P. J. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101955 · Cited by 3
Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT
McManus, D., Copsel, S. N., Pfeiffer, B. J., Wolf, D., Barreras, H., Ma, S., Khodor, A., Komai, S., da Silva, M. B., Hazime, H., et al. (2025) · Blood · doi:10.1182/blood.2025028418 · Cited by 4
Intestinal Dysbiosis in the Infant and the Future of Lacto-Engineering to Shape the Developing Intestinal Microbiome
Zeinali, L. I., Giuliano, S., Lakshminrusimha, S., & Underwood, M. A. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.11.005 · Cited by 3
Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model
Song, Q., Nasri, U., & Zeng, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844271 · Cited by 4
Medication effects on the gut microbiome in allo-HCT
Robinson, W., Gertz, E. M., Greten, T. F., & Ruppin, E. (2023) · Cell · doi:10.1016/j.cell.2023.04.011 · Cited by 3
Treatment of steroid-refractory graft versus host disease in children
Gottardi, F., Leardini, D., Muratore, E., Baccelli, F., Cerasi, S., Venturelli, F., Zanaroli, A., Belotti, T., Prete, A., & Masetti, R. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1251112 · Cited by 3
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors
Felchle, H., Gissibl, J., Rotgerink, L. L., Nefzger, S. M., Walther, C. N., Timnik, V. R., Combs, S. E., & Fischer, J. C. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100758 · Cited by 3
A compilation of fecal microbiome shotgun metagenomics from hospitalized patients undergoing hematopoietic cell transplantationPreprint
Yan, J., Liao, C., Taylor, B. P., Fontana, E., Amoretti, L. A., Wright, R. J., Dai, A., Waters, N. R., Peled, J. U., Taur, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.23.457365 · Cited by 3
Self-citation
GVHD prediction based on the microbiome
Häcker, G. A. (2022) · Blood · doi:10.1182/blood.2022017462 · Cited by 3
The Impact of Health‐Promoting Lifestyle Behaviors on Gut Microbiota in Survivors of Hematological Cancer: A Scoping Review
Samami, E., Starkweather, A. R., Kelly, D. L., & Lyon, D. (2025) · Cancer Reports · doi:10.1002/cnr2.70224 · Cited by 2
Enteral versus parenteral nutrition in auto-HCT: a randomized controlled trial on clinical outcomes and gut microbiome dynamics
Wardill, H. R., van Groningen, L. F. J., Dorraki, M., Molendijk, E. B. D., Kalter, D., Ferreira, A. R. D. S., Kurilshikov, A., Ryan, F. J., Verjans, J. W. H., Harmsen, H. J. M., et al. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09882-z · Cited by 2
Associations Between the Gut Microbiome and Outcomes in Autologous Stem Cell Transplantation: A Systematic Review
Pitts, E., Grainger, B. T., McKenzie, D., & Fiorenza, S. (2025) · Microorganisms · doi:10.3390/microorganisms13102302 · Cited by 2
Changes in the bacterial profile and diversity of the gut microbiota in allogeneic hematopoietic stem cell transplant recipients
González-Rico, C., Hernández, M., Rodríguez-Grande, J., Fernández‐Luis, S., Bermúdez, A., González‐Huerta, A. J., Velasco, E. L., López, L. V., García, I. G., Revillas, F. A. D. L., et al. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108117 · Cited by 2
Pre‐Administration of Akkermansia Muciniphila Prevents the Development of Severe Acute Graft‐Versus‐Host Disease in Systemic Organs
Han, J., Lee, D., Jeong, S., Yun, J., Kang, S., Jang, S., Lee, E., Baek, J. H., Jeon, C. O., & Bae, J. (2025) · Advanced Science · doi:10.1002/advs.202415982 · Cited by 3
The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease
Nishijima, S., Hattori, M., & Nagata, N. (2026) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.102.006 · Cited by 3
The gut microbiome in graft-versus-host disease: mechanisms of immune modulation and therapeutic approaches
Moses, A. B., & Yeh, A. C. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2631224 · Cited by 2
The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
Hao, W., Stocker, N., Gaugler, B., Mohty, M., & Malard, F. (2026) · American Journal of Hematology · doi:10.1002/ajh.70360 · Cited by 2
Assessment of intestinal status in MPLW515L mutant myeloproliferative neoplasms mice model
Zhu, S., Xu, K., Li, S., Yu, X., Liu, Y., Zhang, Q., Zeng, L., Kailin, X., & Xu, K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111091 · Cited by 2
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future
Simunic, M., McGraw, K. L., Pavletic, S. Z., & Rashidi, A. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.10.006 · Cited by 4
Understanding gut Microbiome changes in Korean children, adolescents, and young adults with hematologic malignancies
Park, M., Jung, J., Lee, J. A., Lee, E.-Y., Lee, H., Eom, H., & Park, H. J. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06293-2 · Cited by 2
Sugar‐sensing swodkoreceptors and swodkocrine signaling
Anbalagan, S. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70007 · Cited by 2
A new anchor point for gut microbiome to regulate complications of allogeneic hematopoietic stem cell transplantation: oxidative stress
Bai, W., Jiang, T., Tang, L., Shao, C., Wei, M., Wang, Z., & Zhao, M. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104833 · Cited by 2
Fecal microbiota transplantation for Crohn’s disease-like intestinal lesions arising after allogeneic stem cell transplantation
Kusakabe, S., Kurashige, R., Fukushima, K., Shimizu, K., Yoshihara, T., Motooka, D., Nakamura, S., Kurashige, M., Nakata, K., Hino, A., et al. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-04049-2 · Cited by 2
Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
Kim, S., Lim, S., Razmkhah, F., & Choi, J. (2023) · Blood Research · doi:10.5045/br.2023.2022238 · Cited by 2
Fecal Transplantation in Hematopoietic Transplantation
Peled, J. U., & van den Brink, M. R. M. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01169 · Cited by 2
Self-citation
Secreted antigen A peptidoglycan hydrolase is essential for Enterococcus faecium cell separation and priming of immune checkpoint inhibitor therapy
Klupt, S., Fam, K. T., Zhang, X., Chodisetti, P. K., Mehmood, A., Boyd, T., Grotjahn, D. A., Park, D., & Hang, H. C. (2024) · eLife · doi:10.7554/elife.95297.3 · Cited by 1
Exploring exhaled breath biomarkers for lactose intolerance diagnosis: the Lactobreath pilot study protocol
Giannoukos, S., Burton-Pimentel, K. J., Guillod, R., Vergères, G., & Pohl, D. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-107256 · Cited by 1
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium
Fam, K. T., Chodisetti, P. K., Wang, Z., Homer, J. A., Smedley, C. J., Kitamura, S., Silva, B., Xiong, Y., Hansel-Harris, A., Holcomb, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74057-1 · Cited by 1
The characteristics of the gut microbiota in patients with Kawasaki disease: a systematic review
Chen, H., Liu, H., Qiao, L., Liu, Y., Yu, D., Wang, Z., Wang, T., & Li, W. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1715478 · Cited by 1
Recent advances in the pathophysiology of acute and chronic graft-versus-host disease
Takahashi, S., & Hashimoto, D. (2026) · International Journal of Hematology · doi:10.1007/s12185-026-04177-3 · Cited by 1
Self-citation
The intestinal microbiota as a key modulator of acute graft-versus-host disease
Paredes, J. E., Schmiester, M., Jenq, R. R., & van den Brink, M. R. M. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00910-6 · Cited by 2
Self-citation
Enterococcus faecalis KU-EF-004 enhances efficacy of anti-CTLA-4 immunotherapy for colorectal cancer via dendritic cell activation and gut microbiota modulation
Yamazaki, T., Minami, A., Kitagawa, K., Yanase, S., Ueki, H., & Shirakawa, T. (2026) · BMC Immunology · doi:10.1186/s12865-026-00827-7 · Cited by 1
Fecal Microbiota Transplantation for Gastrointestinal Complications After Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Narrative Synthesis
Liu, S., Huang, Z., & Guo, Z. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.04.016 · Cited by 1
THE MICROBIOME–HOST AXIS IN CANCER THERAPY: MECHANISMS SHAPING IMMUNOTHERAPY EFFICACY AND TREATMENT TOXICITY
Łysiak, J., Abdulgater, A., Stępień, G., Przewoźna, U., Urowska, W., Osuch-Tomaszewska, P., Kossmann, M., Szalewska, L., Burtowicz, J., & Kazubek-Fuksiewicz, I. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5462 · Cited by 1
Isolation and functional characterization of a lytic phage SSBHU against Enterococcus faecium and its potential application in phage therapy
Singh, R. K., Singh, A. K., Anand, R., Rain, Z., Prakash, P. J., Misra, H. S., & Maurya, G. K. (2026) · Biologia · doi:10.1007/s11756-026-02279-1 · Cited by 1
Sugar-rich foods exacerbate antibiotic-induced microbiome disruption
Dai, A., Ballweg, A., Jogia, W., Rangesa, M., Adintori, P. A., Baichoo, M., Funnell, T., Fei, T., Waters, N. R., Swartz, A., et al. (2026) · Nature · doi:10.1038/s41586-026-11077-3 · Cited by 8
Self-citation
Toward Optimizing the Microbiome for Transplant Patients
Markey, K. A. (2022) · The Hematologist · doi:10.1182/hem.v19.5.2022512 · Cited by 1
Self-citation
The inflammasome in graft-versus-host disease
Hamarsheh, S., & Zeiser, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00005-0 · Cited by 1
Individuals, Boundaries, and Graft-versus-Host Disease
Deeg, H. J. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.09.001 · Cited by 1
GUT MICROBIOTA EFFECTS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
Gürer, E. E., Oğuz, F. S., Beşışık, S. K., Aktaş, Z., Gülbaş, Z., Öncül, M., & Sezerman, O. U. (2022) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.1027106 · Cited by 1
Targeting the gut microbiome in allogeneic hematopoietic stem cell transplantationPreprint
de Leeuw, M. A., & Duval, M. X. (2020) · medRxiv · doi:10.1101/2020.04.08.20058198 · Cited by 1
Microbiota long-term dynamics and prediction of acute graft-versus-host-disease in pediatric allogeneic stem cell transplantationPreprint
Ingham, A. C., Kielsen, K., Mordhorst, H., Ifversen, M., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2021) · Research Square · doi:10.21203/rs.3.rs-258775/v1 · Cited by 1
Soquelitinib, A Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase (ITK), is Active in Several Murine Models of T Cell-Mediated Inflammatory DiseasePreprint
Hsu, L., Rosenbaum, J. T., Lindner, S., Allanore, Y., Cauvet, A., Pawar, R. D., Li, D., van den Brink, M. R. M., & Miller, R. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.27.564296 · Cited by 1
Secreted antigen A peptidoglycan hydrolase is essential for Enterococcus faecium cell separation and priming of immune checkpoint inhibitor therapyPreprint
Klupt, S., Fam, K. T., Zhang, X., Chodisetti, P. K., Mehmood, A., Boyd, T., Grotjahn, D. A., Park, D., & Hang, H. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.19.567738 · Cited by 1
Secreted antigen A peptidoglycan hydrolase is essential for Enterococcus faecium cell separation and priming of immune checkpoint inhibitor cancer therapyPreprint
Klupt, S., Fam, K. T., Zhang, X., Chodisetti, P. K., Mehmood, A., Boyd, T., Grotjahn, D. A., Park, D., & Hang, H. C. (2024) · eLife · doi:10.7554/elife.95297.1 · Cited by 1
Secreted antigen A peptidoglycan hydrolase is essential for Enterococcus faecium cell separation and priming of immune checkpoint inhibitor therapyPreprint
Klupt, S., Fam, K. T., Zhang, X., Chodisetti, P. K., Mehmood, A., Boyd, T., Grotjahn, D. A., Park, D., & Hang, H. C. (2024) · eLife · doi:10.7554/elife.95297.2 · Cited by 1

Authors: Stein-Thoeringer, C. K., Nichols, K. B., Lazrak, A., Docampo, M. D., Slingerland, A. E., Slingerland, J. B., Clurman, A. G., Armijo, G., Gomes, A. L. C., Shono, Y., Staffas, A., Burgos da Silva, M., Devlin, S. M., Markey, K. A., Bajic, D., Pinedo, R., Tsakmaklis, A., Littmann, E. R., Pastore, A., Taur, Y., Monette, S., Arcila, M. E., Pickard, A. J., Maloy, M., Wright, R. J., Amoretti, L. A., Fontana, E., Pham, D., Jamal, M. A., Weber, D., Sung, A. D., Hashimoto, D., Scheid, C., Xavier, J. B., Messina, J. A., Romero, K., Lew, M., Bush, A., Bohannon, L., Hayasaka, K., Hasegawa, Y., Vehreschild, M. J. G. T., Cross, J. R., Ponce, D. M., Perales, M. A., Giralt, S. A., Jenq, R. R., Teshima, T., Holler, E., Chao, N. J., Pamer, E. G., Peled, J. U., & van den Brink, M. R. M.
Affiliations: Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center (US)
Technical University of Munich (DE)
University of Cologne (DE)
The University of Texas MD Anderson Cancer Center (US)
University Hospital Regensburg (DE)
Duke Medical Center (US)
Hokkaido University (JP)
Duke University (US)
Hokkaido University Hospital (JP)
Goethe University Frankfurt (DE)
ORCID: Stein-Thoeringer, C. K.
Nichols, K. B.
Lazrak, A.
Docampo, M. D.
Slingerland, A. E.
Slingerland, J. B.
Clurman, A. G.
Armijo, G.
Gomes, A. L. C.
Shono, Y.
Staffas, A.
Burgos da Silva, M.
Devlin, S. M.
Markey, K. A.
Bajic, D.
Pinedo, R.
Tsakmaklis, A.
Littmann, E. R.
Pastore, A.
Taur, Y.
Monette, S.
Arcila, M. E.
Pickard, A. J.
Maloy, M.
Wright, R. J.
Amoretti, L. A.
Fontana, E.
Pham, D.
Jamal, M. A.
Weber, D.
Sung, A. D.
Hashimoto, D.
Scheid, C.
Xavier, J. B.
Messina, J. A.
Romero, K.
Lew, M.
Bush, A.
Bohannon, L.
Hasegawa, Y.
Vehreschild, M. J. G. T.
Cross, J. R.
Ponce, D. M.
Perales, M. A.
Giralt, S. A.
Jenq, R. R.
Teshima, T.
Holler, E.
Chao, N. J.
Pamer, E. G.
Peled, J. U.
van den Brink, M. R. M.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2019-11-29
Volume: 366
Issue: 6469
Pages: 1143-1149
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.aax3760
PMC: PMC7003985
OpenAlex: W2990824191
Cited by: 384
References: 55
Citations by year: 2026: 46 · 2025: 60 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 57 · 2020: 39 · 2019: 1
FWCI: 29.38
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
PubMed Central (acceptedVersion)
University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
Funders: National Institutes of Health (1R01HL124112-01A)
National Institute on Aging (P01-AG052359, 2P30AG028716-11)
National Heart, Lung, and Blood Institute (R01-HL125571, R01-HL123340)
National Cancer Institute (R01-CA228358, R01CA203950-01, R01 CA203950-01, P30 CA008748, P01-CA023766, R01-CA228308)
National Institute of Allergy and Infectious Diseases (U01 AI124275, R01 AI032135)
German research Foundation
Topics: Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords: lactose, Enterococcus, graft-versus-host disease, allogeneic hematopoietic stem cell transplantation, lactose malabsorption, gut microbiota, lactose-free diet, bacterial growth substrates, post-transplant mortality, gnotobiotic mouse model
MeSH terms: Gastrointestinal Microbiome, Aged, Animals, Feces, Female, Graft vs Host Disease, Humans, Intestines, Lactose, Male, Middle Aged, RNA, Ribosomal, 16S, Transplantation, Homologous, Enterococcus, Sequence Analysis, RNA, Hematopoietic Stem Cell Transplantation, Mice, Microbiota, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lactose drives Enterococcus expansion to promote graft-versus-host disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks